Larimar Therapeutics Inc. (LRMR)
NASDAQ: LRMR
· Real-Time Price · USD
3.94
0.07 (1.81%)
At close: Sep 05, 2025, 3:59 PM
3.94
0.00%
After-hours: Sep 05, 2025, 04:32 PM EDT
1.81% (1D)
| Bid | 3.81 |
| Market Cap | 337.23M |
| Revenue (ttm) | 482K |
| Net Income (ttm) | -99.79M |
| EPS (ttm) | -1.57 |
| PE Ratio (ttm) | -2.51 |
| Forward PE | -2.28 |
| Analyst | Buy |
| Ask | 4.1 |
| Volume | 1,585,204 |
| Avg. Volume (20D) | 1,416,880 |
| Open | 3.88 |
| Previous Close | 3.87 |
| Day's Range | 3.82 - 4.08 |
| 52-Week Range | 1.61 - 9.50 |
| Beta | 0.92 |
About LRMR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LRMR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LRMR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-3.02%
Larimar Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
8 months ago
-21.72%
Larimar Therapeutics shares are trading lower after the company reported initial data from its ongoing OLE rare disease drug study.
